Monopar Therapeutics Inc Earnings

The next earnings date for Monopar Therapeutics Inc is August 10, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Monopar Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
08/10/2026	$-0.65

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Monopar Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/14/2026	---	$-0.46	46.02%
03/27/2026	---	$-0.64	-27.29%
11/13/2025	Before Market	$-0.48	-9.44%
08/12/2025	Before Market	$-0.35	27.30%
05/13/2025	Before Market	$-0.38	45.21%
03/31/2025	Before Market	$-2.75	-541.92%
11/08/2024	Before Market	$-0.37	23.90%
08/09/2024	Before Market	$-0.50	-5.04%
05/09/2024	Before Market	$-0.50	18.30%
03/28/2024	Before Market	$-0.60	24.10%
11/09/2023	Before Market	$-0.70	19.26%
08/10/2023	Before Market	$-0.80	14.75%
05/11/2023	Before Market	$-0.95	16.09%
03/23/2023	Before Market	$-1.15	-10.00%
11/10/2022	Before Market	$-0.95	14.35%
08/11/2022	Before Market	$-1.10	-4.36%
05/12/2022	Before Market	$-0.95	16.28%
03/24/2022	Before Market	$-1.05	-8.36%
11/12/2021	Before Market	$-1	7.73%
08/12/2021	Before Market	$-0.85	13.42%
05/13/2021	After Market	$-0.80	15.97%
03/25/2021	Before Market	$-1	-4.57%
11/12/2020	Before Market	$-0.75	4.09%
08/06/2020	After Market	$-0.70	-52.51%
05/07/2020	Before Market	$-0.50	10.87%
03/27/2020	Before Market	$-0.65	-82.07%

More About Monopar Therapeutics Inc

Website

https://www.monopartx.com

Country

USA

Full Time Employees

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase 1 imaging and dosimetry clinical trial, a radiopharmaceutical imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a Phase1a stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; Excel Diagnostics and Nuclear Oncology Center, for the investigational imaging agent MNPR-101-Zr and investigational therapeutic agent MNPR-101-Lu; license agreement with Alexion to develop and commercialize ALXN1840, a drug candidate for Wilson disease. The company was founded in 2014 and is headquartered in Wilmette, Illinois.

“Monopar Therapeutics Inc Earnings” Can Refer to the Monopar Therapeutics Inc Earnings Date

Some people say “Monopar Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Monopar Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Monopar Therapeutics Inc Stock on the Earnings Date

If you own Monopar Therapeutics Inc stock (MNPR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Monopar Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Monopar Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Monopar Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Monopar Therapeutics Inc earnings or anything else related to the stock market.